Ocular Therapeutix
OCUL
#5415
Rank
โ‚น145.32 B
Marketcap
โ‚น661.73
Share price
-4.65%
Change (1 day)
-36.63%
Change (1 year)

Earnings for Ocular Therapeutix (OCUL)

Earnings in 2026 (TTM): -โ‚น27.74 Billion

According to Ocular Therapeutix's latest financial reports the company's current earnings are โ‚น52.05 Million. In 2025 the company made an earning of -โ‚น25.25 Billion a decrease over its 2024 earnings that were of -โ‚น18.38 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ocular Therapeutix from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น27.74 Billion9.83%
2025 -โ‚น25.25 Billion37.43%
2024 -โ‚น18.38 Billion139.68%
2023 -โ‚น7.67 Billion13.65%
2022 -โ‚น6.75 Billion984.05%
2021 -โ‚น0.63 Billion-95.79%
2020 -โ‚น14.78 Billion80.19%
2019 -โ‚น8.21 Billion44.01%
2018 -โ‚น5.7 Billion-5.38%
2017 -โ‚น6.02 Billion41.79%
2016 -โ‚น4.25 Billion12.47%
2015 -โ‚น3.78 Billion38.75%
2014 -โ‚น2.72 Billion115.12%
2013 -โ‚น1.27 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
SurModics
SRDX
-โ‚น1.07 Billion-96.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Anika Therapeutics
ANIK
-โ‚น0.49 Billion-98.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Intersect ENT
XENT
-โ‚น15.32 Billion-46.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
โ‚น15.22 B-153.18%๐Ÿ‡บ๐Ÿ‡ธ USA